NEW YORK (GenomeWeb) – Pathway Genomics today announced that it has raised $40 million in a Series E round of financing.

"This capital will allow us to continue to expand and validate the tests we offer, grow our sales force, and invest in cutting-edge technology for our CAP- and CLIA-accredited laboratories," Pathway Genomics Founder and CEO Jim Plante said in a statement.

Among the participants in the round is IBM Watson, which is working with Pathway Genomics on the development of a mobile application for personalized health and wellness guidance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.